What helps us in deciding on antidiabetic treatment for individual patients – case reports from routine clinical practice

Czech version

Authors: Zuzana Ondreičková ¹; Martina Gubíková ²; Zbynek Schroner ³
Authors‘ workplace: Diamel s. r. o., Trenčín ¹; Dia vitae s. r. o., Košice ²; SchronerMed, s. r. o., Košice ³
Published in: Diab Obez 2021; 21(41): 39-42
Category:

Labels

Diabetology Obesitology

Diabetologie – obor spolupráce českých a slovenských zdravotníků

The potential of induced pluripotent stem cells in the study and treatment of monogenic diabetes

Discordance between blood glucose and HbA1c – is an explanation possible according to the biokinetic model of glycation?

News in the field of 2nd generation of basal insulin analogs in type 1 diabetes and data from continuous glucose monitoring

Specifics of choosing antidiabetic treatment for elderly patients with type 2 diabetes mellitus

Studies with SGLT2 inhibitors primarily focused on renal parameters in patients with chronic kidney disease with/without type 2 diabetes mellitus

Familial chylomicronemia – pathogenesis, clinical manifestations and a case report

A improving adherence to treatment – metformin XR

What new antidiabetic drugs can do in present clinical practice

Today we can influence overweight and obesity – and thus prevent their consequences, as is the development of diabetes or cardiovascular disease

Education of diabetic patients during the COVID-19 pandemic

Spomienka na primára MUDr. Jindřicha Šimurdu

Viatris Inc. vstupuje aj na slovenský trh ako farmaceutická spoločnosť nového druhu pripravená uspokojovať vyvíjajúce sa potreby zdravotnej starostlivosti na celom svete

Article was published in

Diabetes a obezita

2021 Issue 41